ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 12,100 shares, a decline of 25.3% from the April 30th total of 16,200 shares. Based on an average trading volume of 32,700 shares, the short-interest […]
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report)’s share price crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $50.53 and traded as low as $46.65. ProShares Ultra Nasdaq Biotechnology shares last traded at $47.60, with a volume of 13,107 shares traded. […]
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $52.90 and traded as low as $51.49. ProShares Ultra Nasdaq Biotechnology shares last traded at $52.17, with a volume of 16,677 shares changing hands. ProShares […]
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) shares passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $52.90 and traded as low as $51.49. ProShares Ultra Nasdaq Biotechnology shares last traded at $52.17, with a volume of 16,677 shares trading hands. […]
Cassaday & Co Wealth Management LLC lifted its stake in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) by 1.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,834 shares of the exchange traded fund’s stock after acquiring an additional 521 shares […]